1 / 4

Drug Discovery Products and Services Market

Drug Discovery Products and Services Market

Rohitravan
Download Presentation

Drug Discovery Products and Services Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Discovery Products and Services Market Size, Current Trends, Future Technologies, Growth Overview, Competitive Share Analysis and Expansion Strategies By Regions – Global Forecast to 2023 The Drug Discovery Products and Services Market is growing pervasively mainly due to the augmented demand and supply for the medicines. Moreover, factors such as the increasing technological advancements and the adoption of new techniques for discoveries alongside the rising generic drugs, and the growing number of patents expiries are escalating the market on the global platform. Drug Discovery Services refer to as the outsourcing the process of development of a new medicine. These services minimize the costs and timelines of drug discovery. The most common methods employed for drug discoveries are molecular manipulation, drug metabolites, random screening, molecular designing, and serendipity. The global Drug Discovery Products and Services Market will garner colossal accruals by 2023, registering a CAGR of approximately 10.8% during the assessment period (2017 – 2023). Drug Discovery Products and Services Market – Segments For ease of understanding, the MRFR analysis has been segmented into seven key dynamics: - By Drug Type : Biologics and Small Molecule Drug. By Type of Services : Pharmaceutical Services, Drug Metabolism & Pharmacokinetics (DMPK) Services, Medicinal Chemistry, and Biological Services among others. By Therapeutic Area : Neurology, Oncology, Cardiovascular Diseases, Diabetes Respiratory Diseases, and others. By Process : Target Validation, Target Selection, Hit-To-Lead Identification, Candidate, and Validation Lead Optimization among others. By Technology : Biochips, High Throughput Screening, Pharmacogenomics & Pharmacogenetics, Nanotechnology, Combinatorial Chemistry, Spectroscopy, Metabolomics, and others. By End-user : Pharmaceutical Companies, Hospitals & Clinics, Biotechnology Companies, Research Institutes, and others. By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World. Avail Free Sample at https://www.marketresearchfuture.com/sample_request/5870 Additional factors that are boosting the growth of the market include the increasing research & development activities predominantly led by the government support, burgeoning healthcare sector, the rising demand for generic drugs, increasing geriatric population, and technological advancements. Furthermore, the growing number of contract development and manufacturing organizations (CDMOs) that are fostering the activities of drug discovery and the rapidly proliferating pharmaceutical industry encourage the growth of the market to an extent. Key players leading the global Drug Discovery Products and Services Market include Advinus Therapeutics, Agilent Technologies Ubiquigent, Abbott Laboratories Inc., AstraZeneca PLC, Albany Aurigene, Charles River Laboratories International, Molecular Research Inc. (AMRI), Bayer AG, Eli Lilly and Company, ChemBridge Corporation, Covance, Evotec, Domainex, GE Healthcare, F. Hoffmann-La Market Research Future

  2. Roche Ltd, GenScript, GlaxoSmithKline LLC, GVK Biosciences, Jubilant Biosys, Lonza, Merck, Piramal Enterprises, Promega Corporation, Pharmaceutical Product Development, LLC (PPD), Shimadzu Corp., Selcia Limited, Thermo Fisher Scientific, Syngene International Ltd., SRI International, Viva Biotech, and WuXi AppTec among others. Conversely, the requirement of huge capital investment, low-profit margins, and strict FDA regulations are some of the key factors acting as a headwind that is restricting the growth of market growth. However, factors such as the increasing government assistance, rising funding & reimbursement and improving regulatory framework would support the growth of the market during the assessment period. Also, the growing geriatric population and technological advancements in the medicinal field are contributing to the growth of the market. Browse at https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870 Complete Premium Research Report Enabled with TOC Drug Discovery Products and Services Market – Regional Analysis The North American region, heading with the rising funding from government dominates the global Drug Discovery Products and Services Market. Moreover, factor such as the spreading awareness towards cost- effective applications of drug discovery services and increasing demand for personalized medicines drive the growth of the regional market. The increasing consumption of medicines led by the prevalence of chronic diseases, well-established healthcare sector, and the growing trend of personalized medicines are some of the other key driving forces behind the market growth in the region. Also, factors such as the high healthcare expenditures, and augmenting demand for the novel drug discoveries substantiate the growth of the Drug Discovery Products and Services Market in the North American region. The North America Drug Discovery Products and Services Market is projected to grow at a substantial CAGR, creating a larger revenue pocket by 2023. The Drug Discovery Products and Services Market in the European region accounts for the second-largest market, globally. Factors such as financial support by the government for cancer research activities and the patent expiration of numerous blockbuster drugs are estimated to drive the regional Drug Discovery Products and Services Market. Furthermore, the burgeoning pharmaceutical industry is a key driving force fostering the growth of the regional market and allowing it to grow at a considerable CAGR. The Asia Pacific Drug Discovery Products and Services Market is rapidly emerging as a promising market, globally. The availability of cost-competitive skilled labor force and raw materials are the key driving forces behind the growth of the regional market, encouraging foreign investors to shift their production bases in this rapidly growing market. Additionally, factors such as the huge developments in the pharmaceutical sector, demand for breakthrough drug discoveries, and huge patient pool propels the growth in the regional market. The increasing demand for personalized medicine that is led by the rising prevalence of cancer and other such diseases and presence of a large number of manufacturers of personalized drugs will support the regional market to register a phenomenal CAGR throughout the forecast period. Intended Audience • • • • • Pharmaceutical Companies Research and Development (R&D) Companies Diagnostic Laboratories Government Research Institutes Academic Institutes and Universities Market Research Future

  3. Inquire discount/5870 for an Amazing Discount at https://www.marketresearchfuture.com/check- Drug Discovery Products and Services Market – Competitive Landscape Widely expanded the Drug Discovery Products and Services Market appears to be highly competitive with numerous major and small-scale players forming a competitive landscape. These players compete against each other based on pricing and an array of services. LIST OF TABLES Table 1 Drug Discovery Services Industry Synopsis, 2017–2023 Table 2 Drug Discovery Products and Services Market Estimates and Forecast, 2017–2023, (USD Million) Table 3 Drug Discovery Products and Services Market, By Region, 2017–2023, (USD Million) Table 4 Drug Discovery Products and Services Market, By Drug Type, 2017–2023, (USD Million) Table 5 Drug Discovery Products and Services Market, By Types of Services, 2017–2023, (USD Million) Table 6 Drug Discovery Products and Services Market, By Technology, 2017–2023, (USD Million) Table 7 Drug Discovery Products and Services Market, By Therapeutic Area, 2017–2023, (USD Million) Table 8 Drug Discovery Products and Services Market, By Process, 2017–2023, (USD Million) Table 9 Drug Discovery Products and Services Market, By End-User, 2017–2023, (USD Million) … To be continued. Naturally, the competitive strength of these players is reliant on service pricing, service precision, versatility, and reliability of services. The market is forecasted to witness fierce competition with the potential extensions in innovations. Players operating in the drug discovery market strive to offer unique services with advanced features. About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future Market Research Future

  4. +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future

More Related